DexCom, Inc. (DXCM)
DexCom Market Cap : 28.13B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BioLife Solutions, Inc. | 1.112B |
| Abbott Laboratories | 195.12B |
| Krystal Biotech, Inc. | 7.592B |
| Boston Scientific Corp. | 110.60B |
| Insulet Corp. | 17.02B |
Market Cap Related Metrics
| PE Ratio | 34.92 |
| PS Ratio | 6.356 |
| PEG Ratio | 0.7442 |
| Price to Book Value | 10.24 |
| Price to Free Cash Flow | 27.51 |
| Price | 73.08 |
| Earnings Yield | 2.86% |
| PEGY Ratio | 0.7442 |
| Operating PE Ratio | 32.50 |
| Normalized PE Ratio | 34.92 |